In re: Somaxon Pharmaceuticals Inc
Petitioner: Mylan Inc. and Mylan Pharmaceuticals Inc.
Respondent: Somaxon Pharmaceuticals Inc., Currax Pharmaceuticals LLC, Currax Holdings LLC and Currax Holdings USA LLC
Case Number: 1:2022mc00275
Filed: June 21, 2022
Court: US District Court for the District of Delaware
Nature of Suit: Other Statutory Actions
Jury Demanded By: None
Docket Report

This docket was last retrieved on June 21, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
June 21, 2022 Filing 4 Local Counsel Letter sent. Notice of Compliance deadline set for 7/21/2022. (smg)
June 21, 2022 Filing 3 Record of case transferred in from District of Texas Northern; Case Number in Other District: 3:22-mc-00044. Copy of Docket Sheet and original file
June 21, 2022 Opinion or Order Filing 2 Order Transferring to Another District: Case transferred to Division of United States Court for the District of Delaware. (Ordered by Senior Judge Sam R Cummings on 6/21/2022) (mjr) [Transferred from Texas Northern on 6/21/2022.]
June 21, 2022 Remark: Case submitted for routine judicial assignment. (smg)
June 15, 2022 Filing 1 Motion to Quash Subpoena filed by Mylan Inc. (Filing fee $49; Receipt number 0539-12894857) (Attachments: #1 Exhibit(s) A to Motion to Quash, #2 Exhibit(s) B to Motion to Quash) (Stafford, Nicole) [Transferred from Texas Northern on 6/21/2022.]
June 15, 2022 New Case Notes: A filing fee has been paid. Case preliminarily assigned to Judge Ramirez for items that may be referred. (jmg) [Transferred from Texas Northern on 6/21/2022.]

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: In re: Somaxon Pharmaceuticals Inc
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Respondent: Somaxon Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Respondent: Currax Pharmaceuticals LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Respondent: Currax Holdings LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Respondent: Currax Holdings USA LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Petitioner: Mylan Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Petitioner: Mylan Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?